457 related articles for article (PubMed ID: 26960680)
21. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement.
Gera S; Talluri S; Rangaraj N; Sampathi S
AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300
[TBL] [Abstract][Full Text] [Related]
22. Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment.
Colombo M; de Lima Melchiades G; Michels LR; Figueiró F; Bassani VL; Teixeira HF; Koester LS
AAPS PharmSciTech; 2019 Feb; 20(3):106. PubMed ID: 30746582
[TBL] [Abstract][Full Text] [Related]
23. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.
Marasini N; Tran TH; Poudel BK; Cho HJ; Choi YK; Chi SC; Choi HG; Yong CS; Kim JO
Int J Pharm; 2013 Jan; 441(1-2):424-32. PubMed ID: 23174408
[TBL] [Abstract][Full Text] [Related]
24. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
[TBL] [Abstract][Full Text] [Related]
25. Fusion Method for Solubility and Dissolution Rate Enhancement of Ibuprofen Using Block Copolymer Poloxamer 407.
Dugar RP; Gajera BY; Dave RH
AAPS PharmSciTech; 2016 Dec; 17(6):1428-1440. PubMed ID: 26817763
[TBL] [Abstract][Full Text] [Related]
26. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
27. A new self-microemulsifying mouth dissolving film to improve the oral bioavailability of poorly water soluble drugs.
Xiao L; Yi T; Liu Y
Drug Dev Ind Pharm; 2013 Sep; 39(9):1284-90. PubMed ID: 23009066
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
29. Combined Atomistic Molecular Calculations and Experimental Investigations for the Architecture, Screening, Optimization, and Characterization of Pyrazinamide Containing Oral Film Formulations for Tuberculosis Management.
Adeleke OA; Monama NO; Tsai PC; Sithole HM; Michniak-Kohn BB
Mol Pharm; 2016 Feb; 13(2):456-71. PubMed ID: 26650101
[TBL] [Abstract][Full Text] [Related]
30. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
Yan HM; Sun E; Cui L; Jia XB; Jin X
J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
[TBL] [Abstract][Full Text] [Related]
31. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
32. Acyclovir-Polyethylene Glycol 6000 Binary Dispersions: Mechanistic Insights.
Venkateskumar K; Parasuraman S; Gunasunderi R; Sureshkumar K; Nayak MM; Shah SAA; Khoo K; Kai HW
AAPS PharmSciTech; 2017 Aug; 18(6):2085-2094. PubMed ID: 28004342
[TBL] [Abstract][Full Text] [Related]
33. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
[TBL] [Abstract][Full Text] [Related]
36. Pharmaceutical and pharmacokinetic evaluation of a novel fast dissolving film formulation of flupentixol dihydrochloride.
Abdelbary A; Bendas ER; Ramadan AA; Mostafa DA
AAPS PharmSciTech; 2014 Dec; 15(6):1603-10. PubMed ID: 25142820
[TBL] [Abstract][Full Text] [Related]
37. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
38. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
39. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.
Liu P; Zhou JY; Chang JH; Liu XG; Xue HF; Wang RX; Li ZS; Li CS; Wang J; Liu CZ
Drug Des Devel Ther; 2020; 14():2959-2975. PubMed ID: 32801637
[TBL] [Abstract][Full Text] [Related]
40. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3
Mahajan A; Surti N; Koladiya P
Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
